Prellis Biologics

Provider of 3D bioprinting technology to build human tissues for drug development

placeSan Francisco, California, United States calendar_todayFounded 2016 groups22 employees language prellisbio.com

Registered entities

Social engagement

Social engagement: 15.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Celesta Capital, Avidity Partners, Khosla Ventures, True Ventures.

Investor typeCountShare
Venture capital1179%
Accelerator & incubator214%
Bank & private debt17%

Hiring activity

Hires occasionally

3 roles tracked across 2 of the last 12 months

19 Nov 2025 · Business Development Director/Senior Director · Berkeley

14 Nov 2025 · Director/Sr. Director, Inflammation · Berkeley

Based on job postings tracked across public sources.

Recent activity

23 Sep 2025
Partnership
Eli Lilly and Company
Coming soon